Ask for a Quote:


PharmaceuticalsAntimalarialsOncologyVeterinary SupplementsInjection InstrumentsDiagnostic DetectionIncontinence Products Skin & Wound CareMedical WearCondoms

Request Catalogs:


PharmaceuticalsAntimalarialsOncologyVeterinary SupplementsInjection InstrumentsDiagnostic DetectionIncontinence Products Skin & Wound CareMedical WearCondoms

*AccuQuik™ COVID-19 Test Kit is CE, ISO, USFDA Listed certified.

*AccuQuik™ COVID-19 Test Kit is manufactured in our facilities located in China/India/USA.

(choose the specifications you require below)
Test:

COVID-19 IgG/IgM Rapid Test

Specimen:

Whole Blood/Serum/Plasma

Form:

Cassette

Packaging:

1 cassette/pack, 25 packs/box;1 cassette/pack, 50 packs/box

Request Quotation:

*Once Inquiry List is completed, fill fields below and SEND INQUIRY


Product Information

AdvaCare is a CE, ISO and USFDA Listed manufacturer of COVID-19 (Coronavirus) IgG/IgM Test Kit.

AccuQuik COVID-19 IgG/IgM Rapit Test kit is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG anti-COVID-19 virus and IgM anti-COVID-19 virus in human whole blood, serum, or plasma. It is intended to be used by the professionals as a screening test and as an aid in the diagnosis of infection with COVID-19 viruses (SARS-CoV-2).

Coronaviruses are enveloped RNA viruses that are distributed broadly among humans, other mammals, and birds and that cause respiratory, enteric, hepatic, and neurological diseases. Six coronavirus species are known to cause human diseases. Four viruses – 229E, OC43, NL63, and HKU1 – are prevalent and typically cause common cold symptoms in immunocompetent individuals. The two other strains — severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) — are zoonotic in origin and have been linked to sometimes fatal illness. Given the high prevalence and wide distribution of coronaviruses, the large genetic diversity and frequent recombination of their genomes, and increasing human–animal interface activities, novel coronaviruses are likely to emerge periodically in humans owing to frequent cross-species infections and occasional spillover events.

AccuQuik COVID-19 Rapid Test Kit detects IgG and IgM anti-COVID-19 virus in one test within 10 minutes. The test is user friendly, without cumbersome laboratory equipment, and requires minimal staff trainings.

COVID-19 IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a qualitative membrane-based immunoassay for the detection of COVID-19 antibodies in whole blood, serum, or plasma. This test consists of two components, an IgG component and an IgM component. In the test region, anti-human IgM and IgG is coated. During testing, the specimen reacts with COVID-19 antigen-coated particles in the test strip. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgM or IgG in test line region. If the specimen contains IgM or IgG antibodies to COVID-19, a colored line will appear in test line region.

Therefore, if the specimen contains COVID-19 IgM antibodies, a colored line will appear in test line region M. If the specimen contains COVID-19 IgG antibodies, a colored line will appear in test line region G. If the specimen does not contain COVID-19 antibodies, no colored line will appear in either of the test line regions, indicating a negative result. To serve as a procedural control, a colored line will always appeared in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.

Conversely to Polymerase Chain Reaction test kits (PCR) – in both of their typologies used (such as nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) – used, nowadays, to confirm patients with COVID-19 infection which takes up to 3 hours for results, AccuQuik™ COVID-19 IgG/IgM Rapid Test Kit can detect COVID-19 with an accuracy of 97.9% in ten minutes!

Our COVID-19 rapid test kit is easier to use and can enable more efficient screening among suspected patients. See more about what makes AccuQuik COVID-19 Rapid Test MORE RELIABLE:

Additional Information

Important Notice for Distributors

We, at AdvaCare, have been working around the clock to address this global pandemic, with a special focus on the early detection of COVID-19, to expedite development of our revolutionary testing solution. We stand on the front lines in the fight against novel coronavirus (COVID-19)!

As AdvaCare production lines are running at full capacity to meet demand, delivery times are according to when orders are placed.

Contact us today to Receive Prices, Specifications and Shipment Schedule.

How our Covid-19 Rapid Test Kit Works

The COVID-19 IgM/IgG Rapid Test is a lateral flow immunoassay test device for the rapid presumptive qualitative simultaneous detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human whole blood, serum or plasma specimens from patients suspected of having a SARS-CoV-2 infection by a healthcare provider. Results from the COVID-19 IgM/IgG Rapid Test should not be used as the sole basis for diagnosis. Results for this device must be considered in combination with clinical observations, patient history, epidemiological information, and other relevant diagnostic test results.

In the IgG component of the COVID-19 IgM/IgG Rapid Test, anti-human IgG is coated in the IgG test line region. During testing, the specimen reacts with SARS-CoV-2 antigen-coated particles in the Test Cassette. The mixture then migrates upward on the membrane by capillary action and reacts with the anti-human IgG in the IgG test line region. If the specimen contains IgG antibodies to SARS-CoV-2, a colored line will appear in IgG test line region. In the IgM component of the COVID-19 IgM/IgG Rapid Test, anti-human IgM is coated in the IgM test line region.

During testing the anti-SARS-CoV-2 IgM antibodies, if present in the specimen, react with the SARS-CoV-2 antigen-coated particles in the Test Cassette, and this complex is captured by the anti-human IgM, forming a colored line in the IgM test line region. Therefore, if the specimen contains anti-SARS-CoV-2 IgG antibodies, a colored line will appear in the IgG test line region. If the specimen contains anti-SARS-CoV-2 IgM antibodies, a colored line will appear in the IgM test line region. If the specimen does not contain anti-SARS-CoV-2 antibodies, no colored line will appear in either of the test line regions, indicating a negative result. To serve as a procedural control, a colored line will always appear in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.

AdvaCare Pharma AccuQuik COVID-19 Rapid Test Kit interpretation of results


IgG and IgM are the first antibodies appearing in the human immune system during infection. Because of their high specificity, when detecting acute COVID-19 infection, IgG and IgM antibodies have the advanages of high sensitivity, early diagnosis, and the ability to judge wheather a suspect is infected.

IgG and IgM antibodies can only be produced after several days of viral infection and differ between individuals.

AdvaCare Pharma USA COVID-19 additional information

Benefits of AccuQuik™ COVID-19 Rapid Test Kit

WHAT MAKES AccuQuik™ COVID-19 RAPID TESTS MORE RELIABLE THAN OTHERS?
AccuQuik™ COVID-19 Rapid Tests utilize ONLY high quality monoclonal antibodies (anti-human IgG and anti-human IgM) in the capture zone of our test. The human antibodies in the blood sample attach to a recombinant antigen (the imitation COVID virus) as the specimen flows up the test strip, therefore creating the visible lines that show results (negative, IgG, IgM). The quality of the monoclonal antibodies used in a test determine the intensity and accuracy of the detection lines.
Firstly, the membrane used in AccuQuik™ COVID-19 Rapid Tests are the highest quality ensuring an even flow of antibodies through the capture zone. Secondly, the quality of antibodies in capture zones equate to a higher probability of catching the antibodies to give accurate line results.

FALSE NEGATIVE RESULTS FROM FALSIFIED CLAIMS
Another issue tainting the image and perceived effectiveness of COVID serology tests (rapid tests) is that many rapid test manufacturers simply are untruthful about the claims of the sensitivity of their tests. Several public and private blind trials conducted on many subpar manufacturers have revealed that sensitivity is lower than claimed, resulting in false negative results. The truth is that quality serology tests are effective and dependable – the problem is not the test itself but rather subpar quality of raw materials utilized by manufacturers attempting to cut costs.

False negative results, the most serious impact of low quality COVID serology tests, are life threatening and we fully support the validation of our tests and further regulation by national authorities to eliminate the use of subpar serology tests.

WHY SENSITIVITY OF A RAPID TEST IS MOST IMPORTANT?
The key to the accuracy of a COVID Rapid Test is SENSITIVITY, which measures how often a test generates a positive result for an infected person, influences how visible the detection lines reflect accurate results. Some people naturally have a lower antibody response, depending on the individual and especially common in asymptomatic infected persons, which will not be detected by COVID Rapid Tests with low sensitivity.

HOW TO DETERMINE SENSITIVITY?
The high sensitivity of the AccuQuik™ COVID-19 Rapid Test reflects the high quality of raw materials we utilize. The superior performance of the AccuQuik™ COVID-19 Rapid Test has been validated through a series dilution of COVID-positive reference samples. During the series dilution study, the IgM and IgG test lines of our test remained visible and the test results positive well beyond that of competing tests.

Interested in more Products?

Discover more products we already distribute in more than 65 countries worldwide you can consider to distribute to contain COVID-19 outbreak:

Precautions

  • For professional in vitro diagnostic use only. Do not use after expiration date;
  • Do not eat, drink or smoke in the area where the specimens or kits are handled;
  • Handle all specimens as if they contain infectious agents. Observe established precautions against microbiological hazards throughout testing and follow the standard procedures for proper disposal of specimens;
  • Wear protective clothing such as laboratory coats, disposable gloves and eye protection when specimens are being tested;
  • Humidity and temperature can adversely affect results.

Request
Product Price